All In MedTech

Device Trial Radar · NCT01574664

Evaluation of RFID Localization System for Marking and Retrieving Breast Lesions

A Prospective, Single-Arm, Multicenter Clinical Study to Evaluate the Safety and Performance of the Health Beacons Radiofrequency Identification (RFID) Localization System for Marking and Retrieving Non-Palpable Breast Lesions

Last checked: Nov 20, 2026Latest source record: May 21, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Sep 2012

Primary completion

Mar 2017

Study completion Jun 2017

Sponsor

Lead sponsor
Health BeaconsNot on our public-company list
Sponsor type
Industry
First posted
Apr 10, 2012

More device trials from this sponsor

Design

Study type
Observational
Who can join
Female only, from 18 years, up to 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this investigation is to obtain clinical data to show the Health Beacons Radiofrequency Identification (RFID) Localization System is safe and performs as intended as a localization device for marking and retrieving a non-palpable surgical target from the breast.

Conditions

  • Non-palpable Breast Lesions

Interventions

  • RFID Tag (Health Beacon)Device

    The radiologist or surgeon will place the Health Beacons RFID Tag under ultrasonic or stereotactic guidance. The surgeon will use the Tagfinder to locate the lesion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The surgical target is visualized in the removed specimen AND the RFID Tag was removed from the patient's breast.Time frame: Within 96 hours after lumpectomy

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Sharp Memorial Hospital

    San Diego, California

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.